logoTry Persana

Verge Genomics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Verge Genomics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Verge Genomics company logo

Better drugs, faster. For patients who can’t wait.

Verge Genomics is a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data, focusing on complex diseases like ALS and Parkinson's.

HeadquartersSouth San Francisco, United States
Team size51-100
Founded2015

What is Verge Genomics? - Company Overview & Details

Verge Genomics is Verge Genomics is a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data, focusing on complex diseases like ALS and Parkinson's. Founded in 2015, the company is headquartered in South San Francisco, United States.

Who Founded Verge Genomics?

Verge Genomics was founded by Alice Zhang.

Who are the Key Executives at Verge Genomics? - Leadership Team

Verge Genomics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Verge Genomics

Alice ZhangCEO

Chief Technology Officer (CTO) of Verge Genomics

CTO

About Alice Zhang - CEO of Verge Genomics

Alice Zhang serves as the Chief Executive Officer of Verge Genomics, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Verge Genomics Company Details & Key Information

Where is Verge Genomics located?

Verge Genomics is headquartered in South San Francisco, United States.

How many employees does Verge Genomics have?

Verge Genomics has 51-100 employees.

When was Verge Genomics founded?

Verge Genomics was founded in 2015.

Verge Genomics Official Website

How much funding has Verge Genomics raised?

Verge Genomics has raised $180 Million across 4 funding rounds. The most recent funding was completed on 2022-01-16.

Funding Overview

Verge Genomics has raised a total of $180 million, with a focus on transforming drug discovery using artificial intelligence.

$180 Million
Total Funding Raised
4
Funding Rounds
2022-01-16
Latest Round

Verge Genomics Funding History

Series B
2022-01-16
$98 million
Series A
2018-07-16
$32 million

Who are the key investors in Verge Genomics?

Verge Genomics is backed by 3 key investors including BlackRock, Eli Lilly, Merck Global Health Innovation Fund. These investors focus on Investment management, Financial services, Pharmaceuticals sectors.

Verge Genomics Investor Overview

3
Key Investors
5
Focus Areas
4
Notable Investments

Complete List of Verge Genomics Investors

BlackRock

A major global investment management corporation.

Investment Focus
Investment management
Financial services
Notable Portfolio Companies

Eli Lilly

A global pharmaceutical company.

Investment Focus
Pharmaceuticals
Biotechnology
Notable Portfolio Companies
ALS treatments
Neurodegenerative diseases

Merck Global Health Innovation Fund

A fund focusing on innovative health solutions.

Investment Focus
Healthcare
Biotechnology
Notable Portfolio Companies

What sectors do Verge Genomics investors focus on?

The investors backing Verge Genomics primarily focus on Investment management, Financial services, Pharmaceuticals, Biotechnology, Healthcare sectors.

Investment management
Financial services
Pharmaceuticals
Biotechnology
Healthcare

Featured Investor: BlackRock

BlackRock

A major global investment management corporation.

Notable Investments:

What are Verge Genomics's future plans?

Verge Genomics Verge Genomics aims to advance its drug discovery efforts by leveraging its AI platform.

Verge Genomics Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Verge Genomics face?

Verge Genomics has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Verge Genomics

1

Navigating regulatory approvals

2

Competition in biotechnology

What opportunities does Verge Genomics have?

Verge Genomics has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Verge Genomics

1

Expanding drug pipeline

2

Strengthening partnerships

Verge Genomics Strategic Position Summary

Key Focus Areas

Verge Genomics is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Verge Genomics?

Verge Genomics has 2 recent news updates covering key business developments and market activities.

Verge Genomics News Overview

2
Recent Articles
Active
Media Coverage
2024-11-20
Latest Update

What is Verge Genomics in the news for?

Verge Genomics is currently featured in news for Verge Genomics, Inc. developing novel treatments for amyotrophic lateral sclerosis. and other significant business developments.

Recent News Articles About Verge Genomics

Article 1
2024-11-20

Verge Genomics, Inc. developing novel treatments for amyotrophic lateral sclerosis.

Verge Genomics and Eli Lilly have made significant progress in their collaboration to develop ALS treatments.

tokenist.com
Read News
Article 2
2024-01-08

Verge Genomics, Inc. launches Phase 1b proof-of-concept study of VRG50635.

Verge Genomics announced the initiation of a proof-of-concept study for ALS treatment with VRG50635.

ashlandtownnews.com
Read News

Verge Genomics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Verge Genomics including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Verge Genomics Questions & Answers - Company Information

Q1

What is Verge Genomics?

Verge Genomics is a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data, focusing on complex diseases like ALS and Parkinson's.

Q2

Who founded Verge Genomics?

Verge Genomics was founded by Alice Zhang.

Q3

Who is the CEO of Verge Genomics?

The CEO of Verge Genomics is Alice Zhang. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Verge Genomics raised?

Verge Genomics has raised a total of $$180 Million across 4 funding rounds. The most recent funding was completed on 2022-01-16.

Q5

Who are the investors in Verge Genomics?

Verge Genomics's key investors include BlackRock, Eli Lilly, Merck Global Health Innovation Fund.

Q6

Where is Verge Genomics headquartered?

Verge Genomics is headquartered in South San Francisco, United States.

Q7

When was Verge Genomics founded?

Verge Genomics was founded in 2015.

Q8

How many employees does Verge Genomics have?

Verge Genomics has 51-100 employees.

Q9

What is Verge Genomics's official website?

You can visit Verge Genomics's official website at http://www.vergegenomics.com.

Q10

What was Verge Genomics's latest funding round?

Verge Genomics's latest funding round was a Series B round of $$98 million completed on 2022-01-16.

Q11

Who is founder?

Alice Zhang

Q12

What does the company do?

Verge Genomics transforms drug discovery and development using artificial intelligence (AI) and human data for complex diseases.

Q13

How much funding?

$180 Million

Q14

Latest funding date?

2022-01-16

Q15

Who are the investors?

BlackRock Eli Lilly Merck Global Health Innovation Fund

Q16

What are the challenges?

Navigating regulatory approvals Competition in biotechnology

Q17

What are the opportunities?

Expanding drug pipeline Strengthening partnerships

Q18

Latest news?

Verge Genomics and Eli Lilly have made significant progress in their collaboration to develop ALS treatments. Verge Genomics announced the initiation of a proof-of-concept study for ALS treatment with VRG50635.

More Information About Verge Genomics

For additional details about Verge Genomics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.